205 related articles for article (PubMed ID: 9179369)
1. Clinical relevance of immunoactive mistletoe lectin-I.
Beuth J
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S53-5. PubMed ID: 9179369
[TBL] [Abstract][Full Text] [Related]
2. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe?
Gabius HJ; Gabius S; Joshi SS; Koch B; Schroeder M; Manzke WM; Westerhausen M
Planta Med; 1994 Feb; 60(1):2-7. PubMed ID: 8134410
[TBL] [Abstract][Full Text] [Related]
3. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration.
Kunze E; Schulz H; Gabius HJ
J Cancer Res Clin Oncol; 1998; 124(2):73-87. PubMed ID: 9654190
[TBL] [Abstract][Full Text] [Related]
4. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
Bocci V
J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
[TBL] [Abstract][Full Text] [Related]
5. Effect of immunomodulation with galactoside-specific mistletoe lectin on experimental listeriosis.
Stoffel B; Beuth J; Pulverer G
Zentralbl Bakteriol; 1996 Jul; 284(2-3):439-42. PubMed ID: 8837402
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
Ribéreau-Gayon G; Jung ML; Frantz M; Anton R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
[TBL] [Abstract][Full Text] [Related]
7. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency.
Galanina OE; Kaltner H; Khraltsova LS; Bovin NV; Gabius HJ
J Mol Recognit; 1997; 10(3):139-47. PubMed ID: 9408830
[TBL] [Abstract][Full Text] [Related]
8. Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells.
Kim MS; So HS; Lee KM; Park JS; Lee JH; Moon SK; Ryu DG; Chung SY; Jung BH; Kim YK; Moon G; Park R
Gen Pharmacol; 2000 May; 34(5):349-55. PubMed ID: 11368891
[TBL] [Abstract][Full Text] [Related]
9. [Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties].
Mengs U; Witthohn K; Schwarz T; Lentzen H
Wien Med Wochenschr; 1999; 149(8-10):262-4. PubMed ID: 10483695
[TBL] [Abstract][Full Text] [Related]
10. Mistletoe extract-induced effects on immunocompetent cells: in vitro studies.
Stein GM; Berg PA
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S39-42. PubMed ID: 9179366
[TBL] [Abstract][Full Text] [Related]
11. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
Stein GM; Stettin A; Schultze J; Berg PA
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S57-9. PubMed ID: 9179370
[TBL] [Abstract][Full Text] [Related]
12. Mistletoe lectins and their A and B chains.
Franz H
Oncology; 1986; 43 Suppl 1():23-34. PubMed ID: 3543782
[TBL] [Abstract][Full Text] [Related]
13. [Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks].
Gabius S; Gabius HJ
Dtsch Med Wochenschr; 2002 Mar; 127(9):457-9. PubMed ID: 11870561
[No Abstract] [Full Text] [Related]
14. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
Kunze E; Schulz H; Adamek M; Gabius HJ
J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
16. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.
Hajto T; Hostanska K; Gabius HJ
Cancer Res; 1989 Sep; 49(17):4803-8. PubMed ID: 2758413
[TBL] [Abstract][Full Text] [Related]
17. Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1.
Beuth J; Ko HL; Tunggal L; Steuer MK; Geisel J; Jeljaszewicz J; Pulverer G
In Vivo; 1993; 7(5):407-10. PubMed ID: 8110981
[TBL] [Abstract][Full Text] [Related]
18. [Detection and quantitative determination of lectins and viscotoxins in mistletoe preparations].
Jordan E; Wagner H
Arzneimittelforschung; 1986 Mar; 36(3):428-33. PubMed ID: 3707660
[TBL] [Abstract][Full Text] [Related]
19. Complete amino acid sequence of the B chain of mistletoe lectin I.
Soler MH; Stoeva S; Voelter W
Biochem Biophys Res Commun; 1998 May; 246(3):596-601. PubMed ID: 9618256
[TBL] [Abstract][Full Text] [Related]
20. Immunoprotective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice.
Beuth J; Ko HL; Tunggal L; Buss G; Jeljaszewicz J; Steuer MK; Pulverer G
In Vivo; 1994; 8(6):989-92. PubMed ID: 7772751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
